IPDAnalyticsNewFinal2.png
Subscriber login:
SUBMIT

Remember me

  • Home

  • About IPD

  • Our Solutions

    • US Life-Cycle Insights
    • Global Life-Cycle Insights
    • - Europe
    • - Japan
    • - Canada
    • - Australia
    • - Brazil
    • - Mexico
    • - India
    • - Korea
    • - Russia
    • - China
    • - Taiwan
    • Global Patent Search (GPS)
    • Payer & Provider Insights
    • - Access Hub
    • Market & Financial Insights
    • - Rebate Monitor
    • Coding & Reimbursement
    • Budget Impact
    • Med-Tech Insights
  • Our Subscribers

    • Brand Manufacturers
    • Generic Manufacturers
    • Payers and Managed Care
    • Hospitals and Health Systems
    • Supply Chain Members
    • Institutional Investors
    • Other Industry Stakeholders
  • Podcast

    • Limited Distribution Drugs Part 1 & 2
    • Patient Financial Assistance Programs
    • Drug Pricing and Reimbursement 101
    • Understanding Authorized Generics
    • Manufacturer Life-Cycle Strategies
    • An Inside Look at Formulary Management
    • Provider Strategies for Max Revenue
    • Understanding 505(b)(2)s
    • Skinny Labels and Off-Label Utilization
  • News & Resources

  • Samples

    • Insight Briefs
    • Featured Sample Reports
  • Careers

  • Talk to Us

  • More...

    Use tab to navigate through the menu items.
    • View All
    • News Articles
    • IPD Resources
    Search
    Paths to Approval: Understanding U.S. Regulatory Pathways for Drug Products
    • Dec 24, 2021
    IPD Resources

    Paths to Approval: Understanding U.S. Regulatory Pathways for Drug Products

    This article details the potential regulatory approval pathways.
    Potential Market Exclusivity Granted During U.S. Regulatory Approval Process
    • Dec 23, 2021
    IPD Resources

    Potential Market Exclusivity Granted During U.S. Regulatory Approval Process

    This article explains potential data and market exclusivity granted during the U.S. regulatory approval process.
    Understanding the Process for FDA Approval and Expedited Review
    • Dec 22, 2021
    IPD Resources

    Understanding the Process for FDA Approval and Expedited Review

    This article details the FDA evaluation process and expedited review designations.
    Medical Drug Coding And Reimbursement 101
    • Dec 16, 2021
    IPD Resources

    Medical Drug Coding And Reimbursement 101

    This article explains medical drug coding and reimbursement.
    Drug Pricing Part 2: Generic Drug Pricing
    • Dec 15, 2021
    IPD Resources

    Drug Pricing Part 2: Generic Drug Pricing

    This article explains generic drug pricing, associated terms, including MAC rates and lists, biosimilar pricing, and more.
    Drug Pricing Part 1: Key Terms, Stakeholders, and Brand Drug Pricing Processes
    • Dec 14, 2021
    IPD Resources

    Drug Pricing Part 1: Key Terms, Stakeholders, and Brand Drug Pricing Processes

    This article answers the question, "how does branded drug pricing work?" defining associated terms such as average wholesale price, wholesal
    SquareLogoFinal.jpg
    Asset 211.png
    2020 EOY Regional Award Winner Logo-01.p
    LINKS
    CONTACT & CONNECT
    • Home
    • About IPD
    • Our Solutions
      • US Life-Cycle Insights
      • Global Life-Cycle Insights
      • - Europe
      • - Japan
      • - Canada
      • - Australia
      • - Brazil
      • - Mexico
      • - India
      • - Korea
      • - Russia
      • - China
      • - Taiwan
      • Global Patent Search (GPS)
      • Payer & Provider Insights
      • - Access Hub
      • Market & Financial Insights
      • - Rebate Monitor
      • Coding & Reimbursement
      • Budget Impact
      • Med-Tech Insights
    • Our Subscribers
      • Brand Manufacturers
      • Generic Manufacturers
      • Payers and Managed Care
      • Hospitals and Health Systems
      • Supply Chain Members
      • Institutional Investors
      • Other Industry Stakeholders
    • Podcast
      • Limited Distribution Drugs Part 1 & 2
      • Patient Financial Assistance Programs
      • Drug Pricing and Reimbursement 101
      • Understanding Authorized Generics
      • Manufacturer Life-Cycle Strategies
      • An Inside Look at Formulary Management
      • Provider Strategies for Max Revenue
      • Understanding 505(b)(2)s
      • Skinny Labels and Off-Label Utilization
    • News & Resources
    • Samples
      • Insight Briefs
      • Featured Sample Reports
    • Careers
    • Talk to Us

    Headquarters:

    19950 W Country Club Drive
    7th Floor

    Aventura, FL 33180

    ​

    ​

    Australia

    Brazil

    China

    Germany

    India

    Japan

    Mexico

    Netherlands

    South Korea

    Taiwan

    ​

    info@ipdanalytics.com

    +1 (305) 662-8515

    ​

    ​

    • LinkedIn Social Icon
    • Twitter Social Icon

    © 2022 by IPD Analytics | Privacy Policy

    ​

    OLDIPD-analytics-LOGO.png